Advances in the monitoring of anti-P2Y₁₂ therapy

ISSN： 1369-1635

Source： Platelets, Vol.23, Iss.7, 2012-11, pp. : 510-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-p53 antibodies in patients with dermatomyositis/polymyositis

By Mimura Yoshihiro Yazawa Norihito Tamaki Zenshirou Ashida Ryuichi Jinnin Masatoshi Asano Yoshihide Tada Yayoi Kubo Masahide Ihn Hironobu Tamaki Kunihiko

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1328-1331

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of conventional aggregomerty with VASP for monitoring P2Y12-specifc platelet inhibition

By Aradi Dániel Magyarlaki Tamás Tőkés-Füzesi Margit Rideg Orsolya Vorobcsuk András Komócsi András

Platelets, Vol. 21, Iss. 7, 2010-11 ,pp. : 563-570

Informa Healthcare

Access to resources Recommend Favorite

Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: A new finding that may influence the design of anti-thrombotic agents

By Manolopoulos P. Glenn J. R. Fox S. C. May J. A. Dovlatova N. L. Tang S. -W. Thomas N. R. Ralevic V. Heptinstall S.

Platelets, Vol. 19, Iss. 2, 2008-03 ,pp. : 134-145

Informa Healthcare

Access to resources Recommend Favorite

P2Y12 receptor in platelet activation

By Kim Soochong Kunapuli Satya P.

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite